Silva Krause

Executive Director & Head of Biomarkers Vertex Pharmaceuticals

Seminars

Monday 22nd September 2025
Panel Discussion: Assessing Biopharma Partnership Selection Strategies in Precision Medicine to Strengthen Strategic Partnerships & Accelerate Clinical Success
11:10 am
  • What capabilities, compliance, or market experience drive appetite to collaborate with a particular vendor? And how do different pharma companies prioritize vendor selection considering these criteria?
  • What is the role of cross-functional teams in efficient vendor evaluation across pharma organizations?
  • What is the significance of global vendor footprint in the context of co-development and large scale manufacturing?
  • How are testing decisions around centralized or decentralized testing determined in each market?
Silva Krause